Publicerad: 2026-11-17 14:34 | Uppdaterad: 2026-11-17 14:34

33,9 miljoner från Cancerfonden till forskare på Labmed

12 porträttfoton på forskare som fått anslag från cancerfonden.
Mottagare av anslag från Cancerfonden 2026. Från vänster: Mikael Björnstedt, Jonas Fuxe, Yizhou Hu, Andri Lemarquis, Magdalini Lourda, Helen Kaipe, Anders Mutvei, Dhifaf Sarhan, Matti Sällberg, Oscar Wiklander, Peter Bergman and Stephan Mielke. Foto: N/A

I Cancerfondens senaste utlysning gick 33,9 miljoner kronor till tolv forskare vid institutionen för laboratoriemedicin för åren 2027-2029.

Mikael Björnstedt, Professor

Titel: "Integrated Precision Stratification and Selenium-mediated Targeted Redox Therapy in Resistant Tumors with Special Emphasis on HPB cancers"
Projektanslag, totalsumma: 3 750 000 kr

Jonas Fuxe, Professor

Titel: "Cancer cell plasticity as a driver of immune evasion and lymphatic metastasis"
Projektanslag, totalsumma: 3 750 000 kr

Yizhou Hu, Researcher

Titel: "Defining and targeting the stromal lipid niche in high-risk neuroblastoma through spatial MultiOmics"
Projektanslag, totalsumma: 3 000 000 kr

Andri Lemarquis, Assistant Professor

Titel: "The role of recent thymic emigrants in tumor control"
Projektanslag, totalsumma: 3 000 000 kr

Magdalini Lourda, Docent

Titel: "LUMEN: Liquid biopsy and organoid modelling to understand and predict neurodegeneration in Langerhans cell histiocytosis"
Projektanslag, totalsumma: 3 000 000 kr

Helen Kaipe, Docent

Titel: "Combining tumorreactive T cells and CAF targeting to improve immunotherapy in pancreatic cancer"
Projektanslag, totalsumma: 3 000 000 kr

Anders Mutvei, Docent

Titel: "Lysosome abundance and organization in cancer"
Projektanslag, totalsumma: 3 000 000 kr

Dhifaf Sarhan, Docent

Titel: "Programming adaptive NK cell memory for treatment durability and relapse prevention in high-grade serous ovarian cancer"
Projektanslag, totalsumma: 3 000 000 kr

Matti Sällberg, Professor

Titel: "Genetic vaccines and immune-based therapies to prevent severe liver disease and cancer caused by chronic viral hepatitis: Therapy development and models"
Projektanslag, totalsumma: 3 000 000 kr

Oscar Wiklander, Assistant Professor

Titel: "Extracellular Vesicles as an Integrated Platform for Precision-Guided Cancer Therapy"
Projektanslag, totalsumma: 3 000 000 kr

Peter Bergman, Professor

Titel: "Can a new drug reduce intestinal damage during chemotherapy treatment by activating the natural immunity in the intestinal mucosa?"
Projektanslag, totalsumma: 1 600 000 kr

Stephan Mielke, Professor

Titel: "Early risk stratification in CAR T-cell therapy to improve safety, access and outcome"
Projektanslag, totalsumma: 800 000 kr